Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: What a difference a day makes
Susan G. Blitz
, Peter Cram
, Michael E. Chernew
, Arnold S. Monto
, A. Mark Fendrick
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: What a difference a day makes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Criteria
7%
Decision-analytic Model
7%
Design Decisions
7%
Diagnostic Test
100%
Economic Trade-offs
7%
Incremental Benefits
7%
Incremental Cost
7%
Incremental Value
7%
Influenza
38%
Influenza-like Illness
100%
Inhibitor Therapy
100%
Laboratory Diagnosis
7%
Monetary Value
7%
Narrowband
7%
Neuraminidase Inhibitors
100%
Prediction Rule
7%
Rapid Test
7%
Test Characteristics
7%
Test Cost
7%
Treatment Options
7%
Nursing and Health Professions
Diagnostic Test
7%
Flu Like Syndrome
100%
Infection
7%
Laboratory Diagnosis
7%
Physical Disease by Body Function
7%
Rapid Test
7%
Sialidase Inhibitor
100%